By Abigail Klein Leichman A minimally invasive cryoablation technology for freezing cancerous and benign tumors, developed at IceCure Medical in Israel, proved safe and effective in a three-year trial in the United States. An article in the Annals of Surgical Oncology reports that at a mean of 34.83 months following treatment with IceCure's ProSense cryoablation […]